The Journey of Achieving High Standards in Multiparametric Flow Cytometry Data By Maria Jaimes

The Journey of Achieving High Standards in Multiparametric Flow Cytometry Data By Maria Jaimes

The Live Event Scheduled for 10/26/2022 at 12:00 PM (EDT) has been Cancelled

  • Registration Closed

The Journey of Achieving High Standards in Multiparametric Flow Cytometry Data By Maria Jaimes

About the Presenter

image

Maria Jaimes
VP Application Support
Cytek Biosciences 

Dr. Maria Jaimes earned her MD degree at the Universidad Javeriana in Colombia (South America). Dr. Jaimes completed her postdoctoral training at Stanford University in the department of Microbiology and Immunology. During her postdoc, she worked at characterizing the immune responses to both rotavirus and influenza viruses after natural infection and immunization. In 2005, Dr. Jaimes joined BD Biosciences.  While at BD, Maria worked in different aspects of quality assurance and standardization of flow cytometry assays. Since 2015, Maria has been working at Cytek Biosciences and is part of the R&D team who developed the Aurora Full Spectrum Cytometer. Dr. Jaimes has overseen the instrument characterization, verification and development of multicolor applications. Besides her responsibilities within the R&D team, Dr. Jaimes leads the Technical Applications Support team worldwide

Webinar Summary

Dr. Jaimes will discuss her career in flow cytometry with emphasis on her work around standardization of flow cytometry assays and development of multicolor assays.  Dr. Jaimes will also discuss her journey of applying her knowledge in multicolor flow cytometry into the development of a new technology while working at a start-up, with the motivation of contributing to the generation of high-quality data. Maria will discuss the challenges faced by those dedicated to disseminating best practices in flow cytometry and the role that both academia and industry should play at enforcing those.


CMLE Credit: 1.0

Key:

Complete
Failed
Available
Locked
Webinar
This Live Component has been cancelled.